Danaher Corporation (DHR) Institutional Ownership & Insider Trading

2,099 institutions reported holding Danaher Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 20 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-09-25 · read by EquiReason

DHRDanaher CorporationFollow DHR — free

Diagnostics & Research · Healthcare

—

Price chart with a free account

Market cap: 162.2B
P/E TTM: 37.7
Dividend yield: 0.6%
52-week: —
Next earnings: 26 Jan, in 94 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

2,099 institutions held 82.1% of the shares. Across filers that reported both quarters, shares held changed -0.7%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	2,099	577	-0.7%	588	103	893	159
Mar 26	2,142	571	-0.8%	640	107	797	213
Dec 25	2,254	580	-1.4%	682	166	679	93
Sep 25	2,098	576	+1.9%	588	78	790	90
Jun 25	2,141	574	0.0%	706	96	739	132
Mar 25	2,162	562	-0.1%	669	90	819	173
Dec 24	2,231	572	-1.1%	625	67	778	163
Sep 24	2,208	559	-4.5%	669	133	667	55

Danaher Corporation — questions

Who owns Danaher Corporation stock?: 2,099 institutions reported Danaher Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (7.8%), VANGUARD CAPITAL MANAGEMENT LLC (5.9%), FMR LLC (4.2%).
Are Danaher Corporation insiders buying or selling?: 20 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Danaher Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.